Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W O Bechstein

Showing results (291-300 of 351) with videos related to

Pageof 36
Sort By:
Transplant International : Official Journal of the European Society for Organ Transplantation|December 9, 2000
Perioperative factors influencing patient outcome after liver transplantationA R Mueller, K P Platz, P Krause, et al.
Clinical Transplantation|June 1, 1997
Liver transplantation: treatment of choice for hepatic and neurological manifestation of Wilson's diseaseG Schumacher, K P Platz, A R Mueller, et al.
Transplantation|July 15, 1997
Chronically rejected rat kidney allografts induce donor-specific toleranceS G Tullius, M Nieminen, W O Bechstein, et al.
Transplantation Proceedings|March 27, 2001
Mycophenolate mofetil is superior in combination with tacrolimus compared to cyclosporine for immunosuppressive therapy after liver transplantationM Glanemann, J Klupp, J M Langrehr, et al.
Transplantation Proceedings|December 1, 1994
Outcome following orthotopic liver transplantation in HBsAg-positive patients using short- or long-term immunoprophylaxisH P Lemmens, J M Langrehr, G Blumhardt, et al.
Transplantation Proceedings|February 1, 1997
Distribution of lymphocyte subtypes in liver transplant recipientsN Rayes, W O Bechstein, H P Volk, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1997
Mycophenolate mofetil added to immunosuppression after liver transplantation--first resultsJ Klupp, W O Bechstein, K P Platz, et al.
Transplantation Proceedings|February 1, 1995
Factors relevant to the development of primary dysfunction in liver allograftsG W Haller, J M Langrehr, G Blumhardt, et al.
Transplantation Proceedings|March 20, 1999
Orthotopic liver transplantation for hepatic-associated metabolic disordersJ Pratschke, T Steinmüller, W O Bechstein, et al.
Transplantation Proceedings|December 1, 1994
Fatal graft-versus-host-disease: a grave complication after orthotopic liver transplantationU P Neumann, U Kaisers, J M Langrehr, et al.
Pageof 36

Showing results (291-300 of 351) with videos related to

Sort By:
Pageof 36
Transplant International : Official Journal of the European Society for Organ Transplantation|December 9, 2000
Perioperative factors influencing patient outcome after liver transplantationA R Mueller, K P Platz, P Krause, et al.
Clinical Transplantation|June 1, 1997
Liver transplantation: treatment of choice for hepatic and neurological manifestation of Wilson's diseaseG Schumacher, K P Platz, A R Mueller, et al.
Transplantation|July 15, 1997
Chronically rejected rat kidney allografts induce donor-specific toleranceS G Tullius, M Nieminen, W O Bechstein, et al.
Transplantation Proceedings|March 27, 2001
Mycophenolate mofetil is superior in combination with tacrolimus compared to cyclosporine for immunosuppressive therapy after liver transplantationM Glanemann, J Klupp, J M Langrehr, et al.
Transplantation Proceedings|December 1, 1994
Outcome following orthotopic liver transplantation in HBsAg-positive patients using short- or long-term immunoprophylaxisH P Lemmens, J M Langrehr, G Blumhardt, et al.
Transplantation Proceedings|February 1, 1997
Distribution of lymphocyte subtypes in liver transplant recipientsN Rayes, W O Bechstein, H P Volk, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1997
Mycophenolate mofetil added to immunosuppression after liver transplantation--first resultsJ Klupp, W O Bechstein, K P Platz, et al.
Transplantation Proceedings|February 1, 1995
Factors relevant to the development of primary dysfunction in liver allograftsG W Haller, J M Langrehr, G Blumhardt, et al.
Transplantation Proceedings|March 20, 1999
Orthotopic liver transplantation for hepatic-associated metabolic disordersJ Pratschke, T Steinmüller, W O Bechstein, et al.
Transplantation Proceedings|December 1, 1994
Fatal graft-versus-host-disease: a grave complication after orthotopic liver transplantationU P Neumann, U Kaisers, J M Langrehr, et al.
Pageof 36